Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor

Cancer Research

Volumn 61, Issue 15, 2001, Pages 5784-5789

  Sánchez, Cristina ^a   Gómez del Pulgar, Teresa ^a   Rueda, Daniel ^a   Velasco, Guillermo ^a   Galve Roperh, Ismael ^a   Guzmán, Manuel ^a   De Ceballos, Maria L ^b   Corbacho, Cesar ^c   Ramón y Cajal, Santiago ^c   Huffman, John W ^d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CERAMIDE; PSYCHOTROPIC AGENT; RECEPTOR SUBTYPE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN; CANCER INHIBITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; GLIOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNALIZATION; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASTROCYTOMA; BORNANES; BRAIN NEOPLASMS; CANNABINOIDS; CELL DIVISION; CERAMIDES; GLIOMA; GROWTH INHIBITORS; HUMANS; MICE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035422139     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cannabinoid receptors and their endogenous agonists
2. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
3. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
4. Molecular characterization of a peripheral receptor for cannabinoids
5. Cannabinoid CBI receptors and ligands in vertebrate retina: Localization and function of an endogenous signalling system
6. 1 cannabinoid receptors in human vascular endothelial cells
7. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
8. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
9. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
10. Formation and inactivation of endogenous cannabinoid anandamide
11. A second endogenous cannabinoid that modulates long-term potentiation
12. Control of pain initiation by endogenous cannabinoids
13. Pharmacological and biochemical interactions between opioids and cannabinoids
14. Medicinal applications of δ-9-tetrahydrocannabinol and marijuana
15. The endocannabinoid system as a target for therapeutic drugs
16. Cannabinoids control spasticity and tremor in a multiple sclerosis model
17. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
18. 9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells
19. 9-Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism
20. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
21. 2, a peripheral cannabinoid receptor
22. 2 receptor
23. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
24. Internalization and recycling of the CB1 cannabinoid receptor
25. The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes
26. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
27. 2 cannabinoid receptor
28. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
29. Ceramide: A new second messenger of cannabinoid action
30. Ceramide in the eukaryotic stress response
31. Antineoplastic activity of cannabinoids
32. Control of the cell survival/death decision by cannabinoids
33. New treatment strategies for malignant gliomas
34. Glioblastoma multiforme: The terminator
35. Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic viruses
36. Ceramide-β-D-glucuronide: Synthesis, digestion, and suppression of early markers of colon carcinogenesis
37. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism
38. Δ-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway
39. The genes encoding the peripheral cannabinoid receptor and α-L-fucosidase are located near a newly identified common virus integration site, Evil 1
40. Retroviral insertions in Evil 2, a novel common virus integration site upstream of Tra1/Grp94, frequently coincides with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2